Medicus Pharma (MDCX) announces that its phase 2 clinical study, SKNJCT-003, which is currently underway in nine clinical sites in United ...
Ianalumab, for the treatment of primary immune thrombocytopenia, was granted FDA orphan designation, according to a post on the ...
IPC Indice de Precios Y Cotizaciones 52,926.31 108.56 0.21% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback